Cargando…
Pharmacometabolomics Applied to Personalized Medicine in Urological Cancers
Prostate cancer (PCa), bladder cancer (BCa), and renal cell carcinoma (RCC) are the most common urological cancers, and their incidence has been rising over time. Surgery is the standard treatment for these cancers, but this procedure is only effective when the disease is localized. For metastatic d...
Autores principales: | Amaro, Filipa, Carvalho, Márcia, Bastos, Maria de Lourdes, Guedes de Pinho, Paula, Pinto, Joana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952371/ https://www.ncbi.nlm.nih.gov/pubmed/35337093 http://dx.doi.org/10.3390/ph15030295 |
Ejemplares similares
-
Advances and Perspectives in Prostate Cancer Biomarker Discovery in the Last 5 Years through Tissue and Urine Metabolomics
por: Lima, Ana Rita, et al.
Publicado: (2021) -
A Panel of Urinary Volatile Biomarkers for Differential Diagnosis of Prostate Cancer from Other Urological Cancers
por: Lima, Ana Rita, et al.
Publicado: (2020) -
Sunitinib versus Pazopanib Dilemma in Renal Cell Carcinoma: New Insights into the In Vitro Metabolic Impact, Efficacy, and Safety
por: Amaro, Filipa, et al.
Publicado: (2022) -
Impact of Cork Closures on the Volatile Profile of Sparkling Wines during Bottle Aging
por: Amaro, Filipa, et al.
Publicado: (2022) -
Volatilomics Reveals Potential Biomarkers for Identification of Renal Cell Carcinoma: An In Vitro Approach
por: Amaro, Filipa, et al.
Publicado: (2020)